Skip to main content
. 2020 Oct 1;10(59):36219–36229. doi: 10.1039/d0ra07325c

Fig. 7. Viability assay of both MDA-MB-231 and MCF-7 cells when treated with AptNCL–LipCRM compared to LipCRM. Cells were treated with different concentrations of CRM in LipCRM and AptNCL–LipCRM range from 0 to 40 μM for 72 h (mean ± SD, n = 3).

Fig. 7